AnalysisNews

NEO today

$16.54-$0.29 (-1.72%)close Nov 12, 2026

Trend

DailyDowntrend (confirmed)

4 hourExpanding

1 hourStrong Bearish

15 minStrong Bearish

5 minSymmetric Triangle

Daily trend turns up above $18.15

Key levels

Resistance$20.15

Resistance$17.67

Support$15.90

Support$13.05

Latest news & SEC filings

NewsNeo Performance Materials sets upcoming ex-dividend date

EarningsNeo Performance Materials releases Q3 2026 results, boosts full-year outlook

AnalystTD Cowen Keeps NeoGenomics at Buy, Lifts Price Target to $23

AnalystTD Cowen keeps Buy rating on NeoGenomics, lifts target to $23

All NEO news →

About NeoGenomics

NeoGenomics is a clinical laboratory company focused on cancer diagnostics. It provides testing such as cytogenetics, FISH, flow cytometry, immunohistochemistry, molecular testing, and molecular residual disease testing, plus pathology interpretation and consultative services. Its customers include community oncology and pathology groups, hospitals, academic institutions, and drugmakers. The company runs laboratories in the United States and the United Kingdom.

Based on the company's 10-K filed Feb 17, 2026.

Nasdaq · Healthcare

NEOGENOMICS INC (NEO)

$16.54-0.29 (-1.72%)
WATCHLISTGrade: B+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
16.6017.2317.8718.5016.54Oct 12Oct 20Oct 28Nov 5
High16.69
Low16.11
Open16.45
Volume888K
Avg Vol1.85M
VWAP16.48
30d High19.13
30d Low15.97
30d Chg-10.45%

What Is the Price Target for NEO?

SEPT Low Target

$16.00

SEPT Mid Target

$23.00

SEPT High Target

$28.00

Analyst Consensus

$23.00

Current: $16.83Upside: +36.7%Confidence: 85%Method: Analyst Consensus

Is NEO a Buy or Sell Right Now?

69
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Oct 28▲ UpEarnings3 articles
NeoGenomics shares rose 3.99% to close at $17.99 after the company reported third-quarter adjusted earnings of $0.07 per share, beating the $0.05 estimate, and revenue of $209.254 million, above the $207.328 million estimate. The company also lifted its full-year 2026 revenue outlook to $807 million-$809 million, up from prior guidance of $802 million-$806 million and above the $805.827 million analyst estimate. The stock traded between $17.25 and $18.03 on volume of 2,461,433 shares. The earnings beat and raised guidance are bullish signals that likely drove today's gain.
Critical news
Oct 28HIGHEarnings: growth/beat

Thesis

  • •Revenue growing 10.1% YoY with STABLE trend — consistent growth.
  • •Smart money flows are positive — institutional and insider activity shows net buying.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NEO.

Start Free Trial →

Is NEO Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$18.59

31

Moat Score

NONE

5/9

Piotroski Score

2.5

Altman Z-Score

What Is Smart Money Doing with NEO?

Insider Signal

NEUTRAL

0 buys / 2 sells (90d)

Congress Signal

BUYING

2 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
Stone WarrenofficerBuy17,562-Oct 1, 2026
Stone WarrenofficerSale6,911-Oct 1, 2026
Stone WarrenofficerBuy28,106-Aug 21, 2026
Stone WarrenofficerSale11,060-Aug 21, 2026
Aunan Greg DofficerSale20,000$321KAug 4, 2026
TETRAULT LYNN A.directorSale5,307$60KJun 9, 2026
Kenny John P.directorBuy5,893-Jun 1, 2026
Williams FeliciadirectorBuy23,077-Jun 1, 2026
TETRAULT LYNN A.directorBuy23,077-Jun 1, 2026
Perez David BriandirectorBuy23,077-Jun 1, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

NEO Growth Story

Revenue YoY

10.1%

3yr Revenue CAGR

12.6%

EPS Growth YoY

-35.48%

FCF Growth YoY

36.0%

Revenue Trend

STABLE

Dark Pool Trades for NEO

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for NEO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:21:10$16.54202,700$$3.4MBUY
21:19:49$16.54217,500$$3.6MBUY
21:00:56$16.544,877$$81KBUY
21:00:34$16.541,915$$32KBUY
21:00:34$16.541,303$$22KBUY

5 dark pool trades shown · $$7.1M preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for NEO

PREVIEW

SEPT Investing provides real-time options flow tracking for NEO, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

TypeStrikeExpiryDTEPremiumSizeTrade
CALL$16Nov 208$$922SWEEP

1 options trades shown · 100% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

What Traders Are Saying About NEO

2 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for NEO. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

S
SEPT InvestingVERIFIED122d ago

Zone Setup -- $NEO (NEOGENOMICS INC) Price: $14.11 | Zone: $10.05 to $15.57 Conviction: HIGH Near resistance (74% of range) — breakout watch. Strong positive news (1+ vs 0-)

246 views
S
SEPT InvestingVERIFIED151d ago

SEPT Brain on $NEO -- Bullish Daily uptrend -- support at $8.8. Daily swing structure points higher into new territory with no proven resistance above. Hourly swings confirm the uptrend -- both time...

1 vouches1000 views

Join 3,500+ traders discussing NEO in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for NEOGENOMICS INC (NEO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

NEO — frequently asked questions

What is NEO stock price today?

NEOGENOMICS INC (NEO) is at $16.54, down 1.72% (-$0.29) at the Nov 12, 2026 close.

Why is NEO stock moving today?

Latest NEO news — Nov 11, 2026: Neo Performance Materials sets upcoming ex-dividend date · Nov 10, 2026: Neo Performance Materials releases Q3 2026 results, boosts full-year outlook

Why did NEO stock move on Oct 28, 2026?

NeoGenomics shares rose 3.99% to close at $17.99 after the company reported third-quarter adjusted earnings of $0.07 per share, beating the $0.05 estimate, and revenue of $209.254 million, above the $207.328 million estimate. The company also lifted its full-year 2026 revenue outlook to $807 million-$809 million, up from prior guidance of $802 million-$806 million and above the $805.827 million analyst estimate.

What is the NEO price target?

The average analyst price target for NEO is $23.00, ranging from $16 to $28, based on 7 analysts. Latest: TD Cowen maintains on Oct 30, 2026.

What do analysts rate NEO?

Analyst ratings for NEO: 3 Buy, 8 Hold, 0 Sell — consensus Hold.

Did NEO beat earnings?

NEO last reported on Oct 28, 2026: EPS $0.07 vs $0.06 expected — a beat of 26.1%.

Does NEO pay a dividend?

NEO does not currently pay a dividend.

What are NEO support and resistance levels?

Support: $15.90, $13.05, $11.82. Resistance: $17.67, $20.15.

What are insiders doing with NEO?

Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.

What is the latest news on NEO?

Nov 11, 2026: Neo Performance Materials sets upcoming ex-dividend date · Nov 10, 2026: Neo Performance Materials releases Q3 2026 results, boosts full-year outlook · Oct 30, 2026: TD Cowen Keeps NeoGenomics at Buy, Lifts Price Target to $23